Cilostazol Tablet
Product Images NDC 84386-003

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 84386-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cilostazol Str)

Chemical structure of Cilostazol, depicting its molecular framework including cyclic rings and functional groups. The image includes the chemical notation beneath the structure indicating the name Cilostazol.*

FDA Label Image

Figure 1 (Cilostazol Fig1)

A pharmacokinetic plasma concentration versus time graph depicting Cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol. The y-axis shows plasma concentration in ng/mL, and the x-axis shows time in hours over a 24-hour period, illustrating how drug levels change post-dose.*

FDA Label Image

Figure 2 (Cilostazol Fig2)

A bar chart showing percent mean improvement in maximal walking distance across multiple clinical trials of different durations. The chart compares placebo, Cilostazol 50 mg tablets b.i.d., and Cilostazol 100 mg tablets b.i.d., illustrating varying effectiveness over 12 to 24 weeks in trials with sample sizes ranging from 77 to 431 participants.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablets Bottle))

Label for Cilostazol Tablets, USP 50 mg, oral tablets by Aurobindo Pharma Limited. The carton contains 60 tablets and specifies storage instructions between 20° to 25°C. It includes manufacturer and distributor information, barcode, and notes on drug dispensing and safety.*

FDA Label Image

Package Label-principal Display Panel (100 mg (60 Tablets Bottle))

Label of Cilostazol Tablets, USP 100 mg by Aurobindo Pharma Limited showing a pack of 60 tablets. The label includes dosage strength, storage instructions, distributor Aurobindo Pharma USA, and manufacturer Aurovitas Pharma Taizhou Co., Ltd., with space indicated for coding information such as GTIN and expiry date during packing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.